These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 20300429)

  • 1. Cytokines and their STATs in cutaneous and visceral leishmaniasis.
    Cummings HE; Tuladhar R; Satoskar AR
    J Biomed Biotechnol; 2010; 2010():294389. PubMed ID: 20300429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemokines in host-parasite interactions in leishmaniasis.
    Teixeira MJ; Teixeira CR; Andrade BB; Barral-Netto M; Barral A
    Trends Parasitol; 2006 Jan; 22(1):32-40. PubMed ID: 16310413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunopathogenesis of non-healing American cutaneous leishmaniasis and progressive visceral leishmaniasis.
    Soong L; Henard CA; Melby PC
    Semin Immunopathol; 2012 Nov; 34(6):735-51. PubMed ID: 23053396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokines in the immunity and immunopathogenesis in leishmaniases.
    Saha B; Silvestre R
    Cytokine; 2021 Sep; 145():155320. PubMed ID: 33127260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leishmania major heat shock protein 70 (HSP70) is not protective in murine models of cutaneous leishmaniasis and stimulates strong humoral responses in cutaneous and visceral leishmaniasis patients.
    Rafati S; Gholami E; Hassani N; Ghaemimanesh F; Taslimi Y; Taheri T; Soong L
    Vaccine; 2007 May; 25(21):4159-69. PubMed ID: 17395340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of chemokines in regulation of immunity against leishmaniasis.
    Oghumu S; Lezama-Dávila CM; Isaac-Márquez AP; Satoskar AR
    Exp Parasitol; 2010 Nov; 126(3):389-96. PubMed ID: 20206625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility to leishmaniasis is affected by host SLC11A1 gene polymorphisms: a systematic review and meta-analysis.
    Braliou GG; Kontou PI; Boleti H; Bagos PG
    Parasitol Res; 2019 Aug; 118(8):2329-2342. PubMed ID: 31230160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A historical review of the role of cytokines involved in leishmaniasis.
    Mirzaei A; Maleki M; Masoumi E; Maspi N
    Cytokine; 2021 Sep; 145():155297. PubMed ID: 32972825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Historic Review of the Role of CD4+ T-Cell Subsets in Development of the Immune Responses against Cutaneous and Visceral Leishmaniases.
    Alimohmmadian MH; Ajdary S; Bahrami F
    Iran Biomed J; 2022 Mar; 26(2):99-109. PubMed ID: 35090305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokines in Leishmaniasis: Map of cell movements highlights the landscape of infection and pathogenesis.
    de Araújo FF; Costa-Silva MF; Pereira AAS; Rêgo FD; Pereira VHS; de Souza JP; Fernandes LOB; Martins-Filho OA; Gontijo CMF; Peruhype-Magalhães V; Teixeira-Carvalho A
    Cytokine; 2021 Nov; 147():155339. PubMed ID: 33303311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokines, signaling pathways, and effector molecules required for the control of Leishmania (Viannia) braziliensis in mice.
    Rocha FJ; Schleicher U; Mattner J; Alber G; Bogdan C
    Infect Immun; 2007 Aug; 75(8):3823-32. PubMed ID: 17517868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunopathogenesis of infection with the visceralizing Leishmania species.
    Wilson ME; Jeronimo SM; Pearson RD
    Microb Pathog; 2005 Apr; 38(4):147-60. PubMed ID: 15797810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex-Related Differences in Immune Response and Symptomatic Manifestations to Infection with
    Lockard RD; Wilson ME; Rodríguez NE
    J Immunol Res; 2019; 2019():4103819. PubMed ID: 30756088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coadministration of the Three Antigenic Leishmania infantum Poly (A) Binding Proteins as a DNA Vaccine Induces Protection against Leishmania major Infection in BALB/c Mice.
    Soto M; Corvo L; Garde E; Ramírez L; Iniesta V; Bonay P; Gómez-Nieto C; González VM; Martín ME; Alonso C; Coelho EA; Barral A; Barral-Netto M; Iborra S
    PLoS Negl Trop Dis; 2015 May; 9(5):e0003751. PubMed ID: 25955652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Permissive and protective roles for neutrophils in leishmaniasis.
    Carlsen ED; Liang Y; Shelite TR; Walker DH; Melby PC; Soong L
    Clin Exp Immunol; 2015 Nov; 182(2):109-18. PubMed ID: 26126690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Live Attenuated Leishmania donovani Centrin Knock Out Parasites Generate Non-inferior Protective Immune Response in Aged Mice against Visceral Leishmaniasis.
    Bhattacharya P; Dey R; Dagur PK; Joshi AB; Ismail N; Gannavaram S; Debrabant A; Akue AD; KuKuruga MA; Selvapandiyan A; McCoy JP; Nakhasi HL
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004963. PubMed ID: 27580076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of cellular immunological responses in mono- and polymorphic clinical forms of post-kala-azar dermal leishmaniasis in India.
    Kaushal H; Bras-Gonçalves R; Avishek K; Kumar Deep D; Petitdidier E; Lemesre JL; Papierok G; Kumar S; Ramesh V; Salotra P
    Clin Exp Immunol; 2016 Jul; 185(1):50-60. PubMed ID: 26948150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type I signal peptidase from Leishmania is a target of the immune response in human cutaneous and visceral leishmaniasis.
    Rafati S; Salmanian AH; Taheri T; Masina S; Schaff C; Taslimi Y; Fasel N
    Mol Biochem Parasitol; 2004 May; 135(1):13-20. PubMed ID: 15287582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-protective efficacy of a prophylactic Leishmania donovani DNA vaccine against visceral and cutaneous murine leishmaniasis.
    Aguilar-Be I; da Silva Zardo R; Paraguai de Souza E; Borja-Cabrera GP; Rosado-Vallado M; Mut-Martin M; García-Miss Mdel R; Palatnik de Sousa CB; Dumonteil E
    Infect Immun; 2005 Feb; 73(2):812-9. PubMed ID: 15664920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular and extracellular effector activity of mouse neutrophils in response to cutaneous and visceral Leishmania parasites.
    Valério-Bolas A; Pereira M; Alexandre-Pires G; Santos-Mateus D; Rodrigues A; Rafael-Fernandes M; Gabriel A; Passero F; Santos-Gomes G
    Cell Immunol; 2019 Jan; 335():76-84. PubMed ID: 30424873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.